<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);
    }
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 22.7 - Intracranial Tumours & Hydrocephalus [SDL]</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 22.7 - Intracranial Tumours & Hydrocephalus [SDL] | MD3 SCP Cases">
  <meta name="description" content="Self-directed learning case on brain tumours and hydrocephalus covering classification, presentation, investigations, and management.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:title" content="Case 22.7 - Intracranial Tumours & Hydrocephalus [SDL]">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="Self-directed learning case on brain tumours and hydrocephalus covering classification, presentation, investigations, and management.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <link rel="stylesheet" href="../../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 22.7 – Intracranial Tumours & Hydrocephalus [SDL]</h1>
    <p class="meta"><strong>Category:</strong> Medicine | <strong>Discipline:</strong> Neurology / Neurosurgery | <strong>Setting:</strong> Neurology Outpatient / Hospital Ward</p>

    <h2>Case</h2>
    <p>Laura Kwa is a 39 year old woman who presents with a 3 month history of headaches. The headaches are worse in the morning and have been progressively worsening. Over the last month she has had some vomiting, particularly in the morning. More recently she has noticed some difficulty with balance and coordination. On examination she has papilloedema and ataxia with past-pointing on finger-nose testing. There is also nystagmus on lateral gaze.</p>

    <h2>Questions</h2>

    <div class="question">
      <strong>1. What is the differential diagnosis and most likely location of pathology?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>DIFFERENTIAL DIAGNOSIS:</strong></p>

        <p><strong>The clinical picture suggests a POSTERIOR FOSSA LESION with RAISED INTRACRANIAL PRESSURE</strong></p>

        <p><strong>Key features pointing to posterior fossa (cerebellum/brainstem):</strong></p>
        <ul>
          <li><strong>Cerebellar signs:</strong> Ataxia, past-pointing (dysmetria), nystagmus</li>
          <li><strong>Raised ICP features:</strong> Progressive morning headaches, vomiting (worse in morning), papilloedema</li>
          <li>Posterior fossa lesions cause raised ICP more readily due to obstruction of CSF flow (aqueduct, 4th ventricle)</li>
        </ul>

        <p><strong>DIFFERENTIAL DIAGNOSES:</strong></p>

        <p><strong>1. Posterior Fossa Brain Tumor (MOST LIKELY):</strong></p>
        <ul>
          <li>Subacute progressive symptoms (3 months)</li>
          <li>Cerebellar signs + raised ICP</li>
          <li><strong>Likely tumors in adults (age 39):</strong>
            <ul>
              <li><strong>Metastases:</strong> Most common brain tumors in adults; lung, breast, melanoma, renal, colon</li>
              <li><strong>Hemangioblastoma:</strong> Benign cerebellar tumor; can be sporadic or associated with von Hippel-Lindau disease</li>
              <li><strong>Acoustic neuroma (vestibular schwannoma):</strong> Benign tumor of CN VIII; but usually presents with hearing loss, tinnitus, vertigo rather than ataxia</li>
              <li><strong>Medulloblastoma:</strong> More common in children but can occur in adults</li>
              <li><strong>Ependymoma:</strong> Can arise from 4th ventricle</li>
              <li><strong>Brainstem glioma:</strong> Less common in adults</li>
            </ul>
          </li>
        </ul>

        <p><strong>2. Hydrocephalus (Obstructive):</strong></p>
        <ul>
          <li>Could be caused by posterior fossa tumor obstructing 4th ventricle/aqueduct</li>
          <li>Or primary hydrocephalus (aqueduct stenosis, etc.)</li>
          <li>Symptoms: Headache, vomiting, papilloedema, ataxia (gait disturbance from hydrocephalus)</li>
        </ul>

        <p><strong>3. Cerebellar Stroke (Hemorrhage or Infarction):</strong></p>
        <ul>
          <li>Usually acute/subacute onset (hours to days, not months)</li>
          <li>Can cause cerebellar signs and raised ICP (mass effect, hydrocephalus)</li>
          <li>Less likely given 3-month progressive history</li>
        </ul>

        <p><strong>4. Cerebral Abscess (Posterior Fossa):</strong></p>
        <ul>
          <li>Would expect fever, systemic signs</li>
          <li>Less likely without infective symptoms</li>
        </ul>

        <p><strong>5. Demyelination (Multiple Sclerosis):</strong></p>
        <ul>
          <li>Can cause cerebellar signs</li>
          <li>BUT: Usually relapsing-remitting course, not progressive worsening</li>
          <li>Papilloedema uncommon in MS</li>
        </ul>

        <p><strong>6. Arnold-Chiari Malformation:</strong></p>
        <ul>
          <li>Congenital hindbrain malformation</li>
          <li>Can present in adulthood with cerebellar signs, headaches</li>
          <li>Less likely with papilloedema</li>
        </ul>

        <p><strong>MOST LIKELY DIAGNOSIS: Posterior Fossa Tumor (primary or metastatic) causing obstructive hydrocephalus</strong></p>
      </div>
    </div>

    <div class="question">
      <strong>2. What investigations would you request?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>INVESTIGATIONS FOR SUSPECTED BRAIN TUMOR:</strong></p>

        <p><strong>1. URGENT NEUROIMAGING:</strong></p>

        <p><strong>MRI Brain with Gadolinium Contrast:</strong></p>
        <ul>
          <li><strong>Gold standard for brain tumors</strong></li>
          <li>Superior to CT for:
            <ul>
              <li>Posterior fossa imaging (no bone artifact)</li>
              <li>Tumor characterization</li>
              <li>Detecting smaller lesions</li>
              <li>Assessing extent, edema, mass effect</li>
            </ul>
          </li>
          <li><strong>With gadolinium contrast:</strong> Most tumors enhance (meningioma, metastases, high-grade gliomas); helps differentiate tumor types</li>
          <li>Can assess for hydrocephalus, brainstem involvement</li>
        </ul>

        <p><strong>CT Brain with Contrast (if MRI not available/contraindicated):</strong></p>
        <ul>
          <li>Quicker, more accessible</li>
          <li>Can detect tumor, hydrocephalus, hemorrhage</li>
          <li>Less detail than MRI, especially in posterior fossa</li>
        </ul>

        <p><strong>2. BLOOD TESTS:</strong></p>
        <ul>
          <li><strong>FBC:</strong> Baseline; anemia (chronic disease, bone marrow involvement)</li>
          <li><strong>U&Es, LFTs:</strong> Baseline; assess for organ dysfunction</li>
          <li><strong>Coagulation screen:</strong> Before biopsy/surgery</li>
          <li><strong>Tumor markers (if metastases suspected):</strong>
            <ul>
              <li>CEA (colon cancer)</li>
              <li>CA 19-9 (pancreatic, GI)</li>
              <li>CA 15-3 (breast)</li>
              <li>PSA (prostate)</li>
              <li>AFP, β-hCG (germ cell tumors)</li>
            </ul>
          </li>
        </ul>

        <p><strong>3. INVESTIGATIONS TO FIND PRIMARY (if metastases suspected):</strong></p>
        <ul>
          <li><strong>CT Chest/Abdomen/Pelvis:</strong> Look for primary tumor (lung, kidney, etc.) or other metastases</li>
          <li><strong>Chest X-ray:</strong> Lung cancer screening</li>
          <li><strong>Mammography:</strong> If female and suspected breast cancer</li>
          <li><strong>PET-CT:</strong> If primary unknown; whole-body imaging to detect occult primary/metastases</li>
        </ul>

        <p><strong>4. HISTOLOGICAL DIAGNOSIS:</strong></p>

        <p><strong>Biopsy or Surgical Resection:</strong></p>
        <ul>
          <li><strong>Essential for definitive diagnosis and treatment planning</strong></li>
          <li>Options:
            <ul>
              <li><strong>Surgical resection:</strong> For accessible tumors; provides tissue for histology + therapeutic (debulking)</li>
              <li><strong>Stereotactic biopsy:</strong> For deep/inaccessible lesions; less invasive</li>
            </ul>
          </li>
          <li>Histology determines:
            <ul>
              <li>Tumor type (WHO classification)</li>
              <li>Grade (I-IV for gliomas)</li>
              <li>Molecular markers (IDH mutation, 1p/19q codeletion, MGMT promoter methylation) - guide prognosis and treatment</li>
            </ul>
          </li>
        </ul>

        <p><strong>5. ASSESSMENT OF RAISED ICP/HYDROCEPHALUS:</strong></p>
        <ul>
          <li><strong>Fundoscopy:</strong> Papilloedema (already noted in this case)</li>
          <li><strong>Imaging:</strong> MRI/CT shows ventricular dilatation if hydrocephalus</li>
        </ul>

        <p><strong>6. FUNCTIONAL/COGNITIVE ASSESSMENT:</strong></p>
        <ul>
          <li><strong>Neurological examination:</strong> Baseline deficits</li>
          <li><strong>Performance status (Karnofsky or ECOG):</strong> Important for treatment decisions</li>
          <li><strong>Cognitive assessment:</strong> If symptoms of cognitive impairment</li>
        </ul>

        <p><strong>7. OPHTHALMOLOGY REVIEW (if papilloedema):</strong></p>
        <ul>
          <li>Visual field testing</li>
          <li>Visual acuity</li>
          <li>Monitor for optic atrophy (can occur with chronic papilloedema)</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>3. Describe the classification of intracranial tumors.</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>CLASSIFICATION OF INTRACRANIAL TUMORS:</strong></p>

        <p>Brain tumors can be classified by:</p>
        <ul>
          <li>Primary vs Metastatic</li>
          <li>Cell type of origin (WHO classification)</li>
          <li>Grade (I-IV)</li>
          <li>Location (supratentorial vs infratentorial, intra-axial vs extra-axial)</li>
        </ul>

        <p><strong>I. PRIMARY BRAIN TUMORS:</strong></p>

        <p><strong>A. GLIOMAS (from glial cells - ~30% of brain tumors, ~80% of malignant brain tumors):</strong></p>

        <p><strong>1. Astrocytomas (from astrocytes):</strong></p>
        <ul>
          <li><strong>Grade I (Pilocytic astrocytoma):</strong>
            <ul>
              <li>Benign, slow-growing</li>
              <li>Common in children/young adults</li>
              <li>Cerebellum, optic pathway, brainstem</li>
              <li>Good prognosis; often curable with surgery</li>
            </ul>
          </li>
          <li><strong>Grade II (Diffuse astrocytoma):</strong>
            <ul>
              <li>Low-grade, slow-growing but infiltrative</li>
              <li>Young adults (30s-40s)</li>
              <li>Can progress to higher grade over years</li>
            </ul>
          </li>
          <li><strong>Grade III (Anaplastic astrocytoma):</strong>
            <ul>
              <li>High-grade, malignant</li>
              <li>Faster growing</li>
              <li>Median survival ~2-3 years</li>
            </ul>
          </li>
          <li><strong>Grade IV (Glioblastoma multiforme - GBM):</strong>
            <ul>
              <li><strong>Most common and most aggressive primary brain tumor in adults</strong></li>
              <li>Peak age 50-60 years</li>
              <li>Highly infiltrative, rapid growth</li>
              <li>Poor prognosis: Median survival ~12-15 months despite treatment</li>
              <li>Imaging: Ring-enhancing lesion with central necrosis, extensive edema</li>
            </ul>
          </li>
        </ul>

        <p><strong>2. Oligodendrogliomas:</strong></p>
        <ul>
          <li>Arise from oligodendrocytes</li>
          <li>Grade II (low-grade) or Grade III (anaplastic)</li>
          <li>Adults (peak 40-50 years)</li>
          <li>Often frontal lobe</li>
          <li>Better prognosis than astrocytomas (especially if 1p/19q codeleted)</li>
          <li>Imaging: Calcification common</li>
        </ul>

        <p><strong>3. Ependymomas:</strong></p>
        <ul>
          <li>Arise from ependymal cells lining ventricles</li>
          <li>Can occur at any age</li>
          <li>Location: 4th ventricle (children), spinal cord (adults)</li>
          <li>Can cause hydrocephalus</li>
        </ul>

        <p><strong>B. MENINGIOMAS (~30% of primary brain tumors):</strong></p>
        <ul>
          <li>Arise from meninges (dura mater)</li>
          <li><strong>Usually benign (WHO Grade I ~80%)</strong></li>
          <li>More common in women (2:1); estrogen receptors</li>
          <li>Peak age 60-70 years</li>
          <li>Slow-growing, extra-axial (outside brain parenchyma)</li>
          <li>Common locations: Convexity, falx, parasagittal, sphenoid wing</li>
          <li>Imaging: Homogeneous enhancement, "dural tail" sign</li>
          <li>Treatment: Observation (if small/asymptomatic) or surgical resection</li>
          <li>Rarely malignant (Grade III - atypical or anaplastic meningioma)</li>
        </ul>

        <p><strong>C. PITUITARY TUMORS (~15% of brain tumors):</strong></p>
        <ul>
          <li>Arise from pituitary gland</li>
          <li><strong>Adenomas (benign):</strong>
            <ul>
              <li><strong>Functional:</strong> Secrete hormones (prolactinoma, GH-secreting, ACTH-secreting, TSH-secreting)</li>
              <li><strong>Non-functional:</strong> No hormone secretion; present with mass effect</li>
            </ul>
          </li>
          <li>Symptoms: Hormonal (hyperprolactinemia, Cushing's, acromegaly, hypopituitarism) or mass effect (bitemporal hemianopia from optic chiasm compression, headache)</li>
          <li>Treatment: Medical (dopamine agonists for prolactinomas) or surgical (trans-sphenoidal resection)</li>
        </ul>

        <p><strong>D. SCHWANNOMAS (~8% of brain tumors):</strong></p>
        <ul>
          <li>Arise from Schwann cells of cranial/spinal nerves</li>
          <li><strong>Vestibular schwannoma (Acoustic neuroma):</strong> Most common
            <ul>
              <li>Arises from CN VIII (vestibulocochlear nerve)</li>
              <li>Cerebellopontine angle location</li>
              <li>Symptoms: Unilateral sensorineural hearing loss, tinnitus, vertigo, facial numbness (CN V)</li>
              <li>Benign but can cause significant morbidity</li>
              <li>Associated with Neurofibromatosis Type 2 (bilateral acoustic neuromas)</li>
            </ul>
          </li>
        </ul>

        <p><strong>E. MEDULLOBLASTOMAS:</strong></p>
        <ul>
          <li>Highly malignant (WHO Grade IV)</li>
          <li><strong>Most common malignant brain tumor in children</strong></li>
          <li>Arise from cerebellum (vermis or hemispheres)</li>
          <li>Can spread via CSF (drop metastases to spine)</li>
          <li>Treatment: Surgery + craniospinal radiotherapy + chemotherapy</li>
        </ul>

        <p><strong>F. CNS LYMPHOMA (Primary CNS Lymphoma - PCNSL):</strong></p>
        <ul>
          <li>Usually B-cell non-Hodgkin lymphoma</li>
          <li>Can occur in immunocompetent or immunocompromised (HIV/AIDS, transplant)</li>
          <li>Deep structures (periventricular, basal ganglia, corpus callosum)</li>
          <li>Imaging: Homogeneous enhancement</li>
          <li>Treatment: High-dose methotrexate-based chemotherapy + radiotherapy</li>
        </ul>

        <p><strong>G. OTHER PRIMARY TUMORS:</strong></p>
        <ul>
          <li><strong>Craniopharyngioma:</strong> Benign suprasellar tumor; children and adults; can cause pituitary dysfunction, visual field defects</li>
          <li><strong>Hemangioblastoma:</strong> Benign cerebellar tumor; adults; associated with von Hippel-Lindau disease</li>
          <li><strong>Germ cell tumors:</strong> Pineal region; children/young adults; germinoma, teratoma, etc.</li>
          <li><strong>Choroid plexus tumors:</strong> Rare; papilloma (benign) or carcinoma (malignant)</li>
        </ul>

        <p><strong>II. METASTATIC BRAIN TUMORS (~50% of all brain tumors in adults):</strong></p>

        <p><strong>Most common primary sites:</strong></p>
        <ul>
          <li><strong>Lung</strong> (most common - 40-50%)</li>
          <li><strong>Breast</strong> (15-20%)</li>
          <li><strong>Melanoma</strong> (10% - but melanoma has highest propensity to metastasize to brain)</li>
          <li><strong>Renal cell carcinoma</strong> (5-10%)</li>
          <li><strong>Colorectal</strong> (5%)</li>
        </ul>

        <p><strong>Features:</strong></p>
        <ul>
          <li>Usually <strong>multiple lesions</strong> (but can be solitary)</li>
          <li>Location: Gray-white matter junction (watershed areas)</li>
          <li>Imaging: Ring-enhancing lesions with surrounding edema</li>
          <li>Prognosis generally poor (median survival months), but depends on primary cancer type, extent, and treatment</li>
        </ul>

        <p><strong>ANATOMICAL CLASSIFICATION:</strong></p>

        <p><strong>Supratentorial (above tentorium cerebelli):</strong></p>
        <ul>
          <li>Glioblastoma, astrocytoma, oligodendroglioma, meningioma, metastases, pituitary adenoma</li>
        </ul>

        <p><strong>Infratentorial (posterior fossa - below tentorium):</strong></p>
        <ul>
          <li>Adults: Metastases, hemangioblastoma, acoustic neuroma, meningioma</li>
          <li>Children: Medulloblastoma, pilocytic astrocytoma, ependymoma, brainstem glioma</li>
        </ul>

        <p><strong>Intra-axial (within brain parenchyma):</strong></p>
        <ul>
          <li>Gliomas, metastases, lymphoma</li>
        </ul>

        <p><strong>Extra-axial (outside brain parenchyma):</strong></p>
        <ul>
          <li>Meningioma, schwannoma, pituitary adenoma</li>
        </ul>

        <p><strong>MOLECULAR CLASSIFICATION (increasingly important for prognosis and treatment):</strong></p>
        <ul>
          <li><strong>Gliomas:</strong>
            <ul>
              <li><strong>IDH mutation status:</strong> IDH-mutant has better prognosis than IDH-wildtype</li>
              <li><strong>1p/19q codeletion:</strong> Oligodendroglioma marker; better prognosis, responsive to chemotherapy</li>
              <li><strong>MGMT promoter methylation:</strong> Predicts response to temozolomide in glioblastoma</li>
            </ul>
          </li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>4. What is hydrocephalus? Describe the types, causes, and management.</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>HYDROCEPHALUS</strong></p>

        <p><strong>Definition:</strong> Hydrocephalus is an abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles of the brain, leading to ventricular dilatation and raised intracranial pressure.</p>

        <p><strong>CSF PHYSIOLOGY (normal):</strong></p>
        <ul>
          <li>CSF produced by choroid plexus in lateral ventricles (~500 mL/day)</li>
          <li>Flows: Lateral ventricles → Foramen of Monro → Third ventricle → Aqueduct of Sylvius → Fourth ventricle → Foramina of Luschka (lateral) and Magendie (medial) → Subarachnoid space → Reabsorbed by arachnoid granulations into venous sinuses</li>
          <li>Normal CSF volume: ~150 mL; turnover ~3-4 times per day</li>
        </ul>

        <p><strong>TYPES OF HYDROCEPHALUS:</strong></p>

        <p><strong>1. COMMUNICATING HYDROCEPHALUS (Non-obstructive):</strong></p>
        <ul>
          <li>CSF can flow freely through ventricular system (no obstruction)</li>
          <li>Problem: Impaired CSF reabsorption at arachnoid granulations OR rarely overproduction</li>
        </ul>

        <p><strong>Causes:</strong></p>
        <ul>
          <li><strong>Post-hemorrhagic:</strong> Subarachnoid hemorrhage, intraventricular hemorrhage → blood products block arachnoid granulations</li>
          <li><strong>Post-infectious:</strong> Meningitis (especially TB, bacterial) → inflammation blocks reabsorption</li>
          <li><strong>Idiopathic (Normal Pressure Hydrocephalus - NPH):</strong> See below</li>
          <li><strong>Venous sinus thrombosis:</strong> Impaired venous drainage</li>
          <li><strong>Choroid plexus papilloma:</strong> Overproduction of CSF (rare)</li>
        </ul>

        <p><strong>2. NON-COMMUNICATING HYDROCEPHALUS (Obstructive):</strong></p>
        <ul>
          <li>Obstruction to CSF flow within ventricular system</li>
        </ul>

        <p><strong>Causes by location of obstruction:</strong></p>
        <ul>
          <li><strong>Foramen of Monro:</strong> Colloid cyst, tumor</li>
          <li><strong>Aqueduct of Sylvius:</strong> Congenital aqueductal stenosis, tectal tumor, aqueductal glioma</li>
          <li><strong>Fourth ventricle / Foramina of Luschka & Magendie:</strong> Posterior fossa tumor (medulloblastoma, ependymoma, cerebellar tumor), Chiari malformation, Dandy-Walker malformation</li>
        </ul>

        <p><strong>3. NORMAL PRESSURE HYDROCEPHALUS (NPH):</strong></p>

        <p><strong>Special type of communicating hydrocephalus in elderly:</strong></p>
        <ul>
          <li>Ventriculomegaly with "normal" CSF pressure (or intermittently elevated)</li>
          <li>Peak age 60-70 years</li>
        </ul>

        <p><strong>Classic triad ("Wet, Wobbly, Wacky"):</strong></p>
        <ul>
          <li><strong>Gait disturbance:</strong> "Magnetic" gait (feet appear stuck to floor), shuffling, wide-based, freezing; usually FIRST symptom</li>
          <li><strong>Cognitive impairment:</strong> Dementia (frontal-subcortical pattern), slowed processing, memory problems, apathy</li>
          <li><strong>Urinary incontinence:</strong> Urgency, frequency, incontinence; usually LAST symptom</li>
        </ul>

        <p><strong>Diagnosis:</strong></p>
        <ul>
          <li>MRI/CT: Ventriculomegaly out of proportion to sulcal atrophy</li>
          <li><strong>"Tap test":</strong> Large-volume LP (30-50 mL CSF removed) → temporary improvement in gait suggests NPH will respond to shunting</li>
          <li>CSF opening pressure normal or mildly elevated (\&lt;20 cm H2O)</li>
        </ul>

        <p><strong>Management:</strong></p>
        <ul>
          <li><strong>VP shunt (ventriculoperitoneal shunt):</strong> Can improve symptoms in ~50-80%</li>
          <li>Gait improves most; cognition less reliably improved</li>
          <li>Earlier treatment = better outcomes</li>
        </ul>

        <p><strong>4. CONGENITAL HYDROCEPHALUS:</strong></p>
        <ul>
          <li>Present at birth or develops in infancy</li>
          <li>Causes: Aqueductal stenosis, neural tube defects (spina bifida with Chiari II malformation), Dandy-Walker malformation, congenital infections (TORCH)</li>
          <li>Symptoms in infants: Increasing head circumference (before fontanelles close), bulging fontanelle, "sun-setting" eyes, irritability, vomiting, lethargy</li>
        </ul>

        <p><strong>CLINICAL FEATURES OF HYDROCEPHALUS:</strong></p>

        <p><strong>Acute/Symptomatic Hydrocephalus (raised ICP):</strong></p>
        <ul>
          <li><strong>Headache:</strong> Worse in morning, worse lying down</li>
          <li><strong>Nausea and vomiting:</strong> Especially morning vomiting</li>
          <li><strong>Papilloedema:</strong> Swelling of optic discs</li>
          <li><strong>Visual disturbances:</strong> Blurred vision, diplopia (CN VI palsy), visual field defects</li>
          <li><strong>Altered consciousness:</strong> Drowsiness, confusion, coma</li>
          <li><strong>Cushing's triad (late, pre-terminal):</strong> Hypertension, bradycardia, irregular respirations</li>
        </ul>

        <p><strong>Chronic Hydrocephalus (NPH, congenital):</strong></p>
        <ul>
          <li>Symptoms as per NPH triad or developmental delay in children</li>
        </ul>

        <p><strong>INVESTIGATIONS:</strong></p>

        <p><strong>1. Neuroimaging:</strong></p>
        <ul>
          <li><strong>CT Brain:</strong> Quick, shows ventricular dilatation, can identify obstruction</li>
          <li><strong>MRI Brain:</strong> Better anatomical detail; can identify cause (tumor, aqueduct stenosis, etc.); shows CSF flow</li>
          <li><strong>Key findings:</strong>
            <ul>
              <li>Enlarged ventricles</li>
              <li>Periventricular lucency (transependymal CSF flow)</li>
              <li>Effacement of sulci (if raised ICP)</li>
            </ul>
          </li>
        </ul>

        <p><strong>2. Fundoscopy:</strong></p>
        <ul>
          <li>Papilloedema (if acute raised ICP)</li>
        </ul>

        <p><strong>3. Lumbar Puncture (ONLY if communicating hydrocephalus and no raised ICP):</strong></p>
        <ul>
          <li>Opening pressure</li>
          <li>Tap test for NPH</li>
          <li><strong>CONTRAINDICATED if obstructive hydrocephalus</strong> (risk of herniation)</li>
        </ul>

        <p><strong>MANAGEMENT OF HYDROCEPHALUS:</strong></p>

        <p><strong>1. TREAT UNDERLYING CAUSE (if possible):</strong></p>
        <ul>
          <li>Tumor resection (if obstructing tumor)</li>
          <li>Treat meningitis/SAH</li>
        </ul>

        <p><strong>2. EMERGENCY MANAGEMENT (if acute symptomatic hydrocephalus):</strong></p>

        <p><strong>Medical:</strong></p>
        <ul>
          <li><strong>Raise head of bed 30°</strong></li>
          <li><strong>Osmotherapy:</strong> Mannitol or hypertonic saline (temporary measure)</li>
          <li><strong>Acetazolamide:</strong> Reduces CSF production (limited role; mainly in chronic cases)</li>
          <li><strong>Steroids (dexamethasone):</strong> If vasogenic edema from tumor</li>
        </ul>

        <p><strong>Surgical (definitive):</strong></p>
        <ul>
          <li><strong>External Ventricular Drain (EVD):</strong>
            <ul>
              <li>Temporary measure for acute hydrocephalus</li>
              <li>Catheter inserted into lateral ventricle, drains CSF externally</li>
              <li>Used in emergency or as bridge to definitive treatment</li>
            </ul>
          </li>
          <li><strong>VP Shunt (Ventriculoperitoneal Shunt):</strong>
            <ul>
              <li><strong>Definitive treatment for chronic hydrocephalus</strong></li>
              <li>Catheter from lateral ventricle → tunneled under skin → drains CSF into peritoneal cavity</li>
              <li>Valve regulates flow</li>
              <li><strong>Complications:</strong> Infection, blockage, over-drainage (subdural hematoma), under-drainage</li>
              <li>May require lifelong</li>
            </ul>
          </li>
          <li><strong>Endoscopic Third Ventriculostomy (ETV):</strong>
            <ul>
              <li>For obstructive hydrocephalus (e.g., aqueduct stenosis)</li>
              <li>Creates opening in floor of third ventricle → CSF bypasses obstruction → flows to basal cisterns</li>
              <li>Avoids need for shunt (no foreign body, lower infection risk)</li>
              <li>Not suitable for communicating hydrocephalus</li>
            </ul>
          </li>
        </ul>

        <p><strong>3. MONITORING:</strong></p>
        <ul>
          <li>Serial imaging to assess ventricular size</li>
          <li>Neurology/neurosurgery follow-up</li>
          <li>Shunt function monitoring (if shunt in situ)</li>
        </ul>

        <p><strong>PROGNOSIS:</strong></p>
        <ul>
          <li>Depends on cause and timing of treatment</li>
          <li>Untreated acute hydrocephalus → herniation → death</li>
          <li>With treatment (shunt), many patients can lead normal lives</li>
          <li>NPH: Earlier treatment = better outcomes; gait improves most</li>
          <li>Congenital hydrocephalus: Variable outcomes; early treatment important to prevent developmental delay</li>
        </ul>
      </div>
    </div>

  </div>

  <!-- JavaScript -->  <script src="../../js/firebase-config.js"></script>
  <script src="../../js/dark-mode.js"></script>
  <script src="../../js/auth.js"></script>
  <script src="../../js/user-analytics.js"></script>
  <script src="../../js/analytics-integration.js"></script>
  <script src="../../js/completion-tracker.js"></script>
  <script src="../../js/flag-tracker.js"></script>
  <script src="../../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        
    }
      
    }
    
    }
// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      
    }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      
    }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          
    }
        }, 100);
      
    }
    });
    
    }
  </script>

</body>
</html>
